{"id":"NCT05197257","sponsor":"University of Colorado, Denver","briefTitle":"68Ga-PSMA-11 PET in Patients With Prostate Cancer","officialTitle":"68Ga-PSMA-11 PET in Patients With Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-09-29","primaryCompletion":"2022-04-14","completion":"2022-04-14","firstPosted":"2022-01-19","resultsPosted":"2023-11-13","lastUpdate":"2023-11-13"},"enrollment":39,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostate Cancer","Prostate Adenocarcinoma"],"interventions":[{"type":"DRUG","name":"Ga-PSMA-11","otherNames":[]}],"arms":[{"label":"Men with pathologically proven prostate adenocarcinoma","type":"EXPERIMENTAL"}],"summary":"Patients will receive a single dose of 68Ga-PSMA-11 and undergo a PET/CT or PET/MRI imaging study.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"Immediately after administration and for 1 hour and 30 minutes afterwards","effectByArm":[{"arm":"Adverse Events- All Grades","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":39},"commonTop":[]}}